Case Study: Merck accelerates drug development with Revolution Analytics' gsDesign Explorer

Merck Optimizes Critical Drug Development with Revolution Analytics gsDesign Explorer

Merck Research Laboratories faced the challenge of creating and comparing group sequential clinical trial designs without programming, a need that slowed drug development and added cost during the research process. To address this, Merck used Revolution Analytics’ gsDesign Explorer, a GUI built on the R-based gsDesign package to help statisticians explore adaptive trial designs more efficiently.

Revolution Analytics implemented gsDesign Explorer to simplify trial design analysis with intuitive, well-documented tools for generating summaries and visualizations. The result was faster data analysis and the ability to advance promising drugs sooner; Merck reported that appropriate futility analyses could save about $10 million per trial, and noted that gsDesign Explorer enabled a trial they otherwise could not have done.

Merck